What's Happening?
Sartorius has sponsored an infographic comparing methods for achieving monoclonal cell lines, highlighting a next-generation alternative to traditional nanowell-based image-verified cloning. Cell-line
development (CLD) is essential for producing therapeutic biomolecules, starting with the isolation of single cells to form high-yield colonies. The infographic outlines three methods for single-cell isolation and cloning, emphasizing the challenges of time and resource intensity in the process. The new approach aims to streamline the initial isolation step, setting a foundation for high-throughput, viable monoclonal cell lines. This development is crucial for advancing drug discovery and development, offering potential improvements in efficiency and yield.
Why It's Important?
The introduction of a next-generation cloning method by Sartorius could significantly impact the biotechnology and pharmaceutical industries. By improving the efficiency of cell-line development, this method may accelerate the production of therapeutic biomolecules, potentially reducing costs and time associated with drug development. This advancement could lead to more rapid innovation in treatments for various diseases, benefiting both companies and patients. The focus on high-throughput and viable monoclonal cell lines aligns with industry goals to enhance productivity and reliability in biomanufacturing processes.
